Citations to this article

Sizhi Paul Gao, Kevin G. Mark, Kenneth Leslie, William Pao, Noriko Motoi, William L. Gerald, William D. Travis, William Bornmann, Darren Veach, Bayard Clarkson, Jacqueline F. Bromberg
Published in Volume 117, Issue 12
J Clin Invest. 2007; 117(12):3846–3856 doi:10.1172/JCI31871

Total citations by year in Crossref

Year: 2013 2012 2011 2010 2009 2008 2007 Total
Citations: 5 13 16 17 24 11 1 87
Citation information

Citations to this article in Crossref (87)

Title and authors Publication Year
Reactive oxygen species involved in sulforaphane-induced STAT3 inactivation and apoptosis in DU145 prostate cancer cells
W Koh, KS Ahn, SJ Jeong, HJ Lee, M Kim, HJ Lee, EO Lee, SH Kim
Chinese Science Bulletin 2010
Loss of annexin A1 disrupts normal prostate glandular structure by inducing autocrine IL-6 signaling
J Inokuchi, A Lau, DR Tyson, DK Ornstein
Carcinogenesis 2009
IL-6/gp130/STAT3 signaling axis in cancer and the presence of in-frame gp130 somatic deletions in inflammatory hepatocellular tumors
R Rosell, J Bertran-Alamillo, MA Molina, M Taron
Future Oncology 2009
The JAK2 Inhibitor AZD1480 Potently Blocks Stat3 Signaling and Oncogenesis in Solid Tumors
M Hedvat, D Huszar, A Herrmann, JM Gozgit, A Schroeder, A Sheehy, R Buettner, D Proia, CM Kowolik, H Xin, B Armstrong, G Bebernitz, S Weng, L Wang, M Ye, K McEachern, H Chen, D Morosini, K Bell, M Alimzhanov, S Ioannidis, P McCoon, ZA Cao, H Yu, R Jove, M Zinda
Cancer Cell 2009
A component of polysaccharide peptidoglycan complex onLactobacillusinduced an improvement of murine model of inflammatory bowel disease and colitis-associated cancer
S Matsumoto, T Hara, M Nagaoka, A Mike, K Mitsuyama, T Sako, M Yamamoto, S Kado, T Takada
Immunology 2009
Janus Kinase Mutations
RL Levine
Seminars in Oncology 2009
Combined targeting of interleukin-6 and vascular endothelial growth factor potently inhibits glioma growth and invasiveness
A Saidi, M Hagedorn, N Allain, C Verpelli, C Sala, L Bello, A Bikfalvi, S Javerzat
International Journal of Cancer 2009
STAT3 tyrosine phosphorylation is critical for interleukin 1 beta and interleukin-6 production in response to lipopolysaccharide and live bacteria
L Samavati, R Rastogi, W Du, M Hüttemann, A Fite, L Franchi
Molecular Immunology 2009
STATs in cancer inflammation and immunity: a leading role for STAT3
H Yu, D Pardoll, R Jove
Nature Reviews Cancer 2009
The VE-cadherin binding domain of fibrinogen induces endothelial barrier permeability and enhances transendothelial migration of malignant breast epithelial cells
A Sahni, MT Arévalo, SK Sahni, PJ Simpson-Haidaris
International Journal of Cancer 2009
Alternative implication of CXCR4 in JAK2/STAT3 activation in small cell lung cancer
M Pfeiffer, TN Hartmann, M Leick, J Catusse, A Schmitt-Graeff, M Burger
British Journal of Cancer 2009
Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability
F Colotta, P Allavena, A Sica, C Garlanda, A Mantovani
Carcinogenesis 2009
Ikappa B kinaseβ/nuclear factor-κB activation controls the development of liver metastasis by way of interleukin-6 expression
S Maeda, Y Hikiba, K Sakamoto, H Nakagawa, Y Hirata, Y Hayakawa, A Yanai, K Ogura, M Karin, M Omata
Hepatology 2009
Mitochondrial STAT3 Supports Ras-Dependent Oncogenic Transformation
DJ Gough, A Corlett, K Schlessinger, J Wegrzyn, AC Larner, DE Levy
Science 2009
The role of proto-oncogene Fra-1 in remodeling the tumor microenvironment in support of breast tumor cell invasion and progression
YP Luo, H Zhou, J Krueger, C Kaplan, D Liao, D Markowitz, C Liu, T Chen, TH Chuang, R Xiang, RA Reisfeld
Oncogene 2009
Interleukin 6 secreted from adipose stromal cells promotes migration and invasion of breast cancer cells
M Walter, S Liang, S Ghosh, PJ Hornsby, R Li
Oncogene 2009
Serum levels of nicotinamide N-methyltransferase in patients with lung cancer
M Tomida, I Mikami, S Takeuchi, H Nishimura, H Akiyama
Journal of Cancer Research and Clinical Oncology 2009
Mina53, a novel c-Myc target gene, is frequently expressed in lung cancers and exerts oncogenic property in NIH/3T3 cells
K Komiya, N Sueoka-Aragane, A Sato, T Hisatomi, T Sakuragi, M Mitsuoka, T Sato, S Hayashi, H Izumi, M Tsuneoka, E Sueoka
Journal of Cancer Research and Clinical Oncology 2009
Immune Therapy for Cancer
M Dougan, G Dranoff
Annual Review of Immunology 2009
IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer
S Grivennikov, E Karin, J Terzic, D Mucida, GY Yu, S Vallabhapurapu, J Scheller, S Rose-John, H Cheroutre, L Eckmann, M Karin
Cancer Cell 2009
Stat3 downstream genes serve as biomarkers in human lung carcinomas and chronic obstructive pulmonary disease
P Qu, J Roberts, Y Li, M Albrecht, OW Cummings, JN Eble, H Du, C Yan
Lung cancer (Amsterdam, Netherlands) 2009
ErbB receptors and signaling pathways in cancer
NE Hynes, G MacDonald
Current Opinion in Cell Biology 2009
gp130-Mediated Stat3 Activation in Enterocytes Regulates Cell Survival and Cell-Cycle Progression during Colitis-Associated Tumorigenesis
J Bollrath, TJ Phesse, VA von Burstin, T Putoczki, M Bennecke, T Bateman, T Nebelsiek, T Lundgren-May, Ö Canli, S Schwitalla, V Matthews, RM Schmid, T Kirchner, MC Arkan, M Ernst, FR Greten
Cancer Cell 2009
Interleukin-6-producing undifferentiated thymic carcinoma with neuroendocrine features
M Suzuki, N Shinagawa, S Oizumi, K Fugo, M Nishimura
Lung Cancer 2009
Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non–Small-Cell Lung Cancers Dependent on the Epidermal Growth Factor Receptor Pathway
KS Nguyen, S Kobayashi, DB Costa
Clinical Lung Cancer 2009